NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab

BACKGROUND: Early identification of cardiac dysfunction by non-invasive imaging in HER2-positive breast cancer patients treated with trastuzumab is challenging. In particular multigated acquisition (MUGA) scan, which is most widely used, is unable to detect subclinical cardiac changes. The use of N-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouwer, Nathalie I., Liesting, Crista, Kofflard, Marcel J. M., Sprangers-van Campen, Sylvia M., Brugts, Jasper J., Kitzen, Jos J. E. M., Fouraux, Michael A., Levin, Mark-David, Boersma, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048136/
https://www.ncbi.nlm.nih.gov/pubmed/32154011
http://dx.doi.org/10.1186/s40959-019-0039-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048136/
https://www.ncbi.nlm.nih.gov/pubmed/32154011
http://dx.doi.org/10.1186/s40959-019-0039-4

Ejemplares similares